ReviewCancers2018
Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance.
Zachary Schrank et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
78 papers cite itlatest 60 shown
this paperpooled itcites it
ReviewCancers2018
Zachary Schrank et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.